This trial is comparing two different treatments for degenerative disc disease, both of which involve platelets. One group will receive the treatment 4 weeks apart, and the other group will receive sham procedures.
1 Primary · 7 Secondary · Reporting Duration: 1-month, 3-months, 6 months, 12 months
Experimental Treatment
Non-Treatment Group
42 Total Participants · 2 Treatment Groups
Primary Treatment: Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP) · Has Placebo Group · N/A
Age 25 - 65 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:| Utah | 33.3% |
| Hawaii | 33.3% |
| Iowa | 33.3% |
| 18 - 65 | 100.0% |
| Centeno-Schultz Clinic | 100.0% |
| Did not meet criteria | 66.7% |
| Met criteria | 33.3% |
| 100.0% | |